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AMP-activated protein kinase (AMPK) is a cen-
tral regulator of energy homeostasis in mam-
mals. AMP is believed to control the activity
of AMPK by binding to the g subunit of this het-
erotrimeric enzyme. This subunit contains two
Bateman domains, each of which is composed
of a tandem pair of cystathionine b-synthase
(CBS) motifs. No structural information is cur-
rently available on this subunit, and themolecu-
lar basis for its interactions with AMP is not well
understood.We report here thecrystal structure
at 1.9 A˚ resolution of the Bateman2 domain of
Snf4, the g subunit of the yeast ortholog of
AMPK. The structure revealed a dimer of the
Bateman2 domain, and this dimerization is
supported by our light-scattering,mutagenesis,
and biochemical studies. There is a prominent
pocket at the center of this dimer, and most of
the disease-causing mutations are located in
or near this pocket.
INTRODUCTION
AMP-activated protein kinase (AMPK) is a central regulator
of energy homeostasis in mammals (Carling, 2005; Hardie
et al., 1998; Hardie and Sakamoto, 2006; Kahn et al., 2005;
Kemp et al., 2003; Viollet et al., 2003). An elevated
AMP:ATP concentration ratio (signifying energy depletion)
leads to the activation of AMPK, which in turn shuts off
energy-demanding, anabolic processes and stimulates
energy-producing, catabolic processes. On the other
hand, ATP is an inhibitor of AMPK activity. The therapeutic
effects of metformin and rosiglitazone, two commonly
used drugs against type 2 diabetes, are likely derived
from their (indirect) activation of AMPK, making AMPK an
important target for drug development against diabetes,
obesity, and other diseases (Hardie and Sakamoto,
2006; Kahn et al., 2005).
AMPK is a heterotrimeric enzyme, consisting of one
catalytic (a) and two regulatory (b and g) subunits (HardieStructure 15,et al., 1998; Hardie and Sakamoto, 2006; Kahn et al.,
2005). Different isoforms of these subunits exist in mam-
mals (a1, a2, b1, b2, g1, g2, and g3), giving rise to the
potential for many distinct AMPK complexes. Theasubunit
contains the Ser/Thr protein kinase domain (Hardie et al.,
1998; Hardie and Sakamoto, 2006; Kahn et al., 2005), the
crystal structure of which has recently been reported
(Nayak et al., 2006; Rudolph et al., 2005), an autoinhibitory
domain (Crute et al., 1998), and regions that are important
for interacting with the regulatory subunits. The b subunit
contains a glycogen-binding domain (Polekhina et al.,
2005) and regions that are important for the formation of
the trimeric complex.
The g subunit contains four repeats of the cystathionine
b-synthase (CBS) motif (Figure 1). CBS motifs contain
about 60 amino acid residues and have been found in
a variety of proteins from bacteria, archaea, and eukary-
otes (Bateman, 1997). The motifs generally occur as tan-
dem pairs, and each pair of CBS motifs is also known as
a Bateman domain (Kemp, 2004). The g subunit of mam-
malian AMPK therefore contains two Bateman domains
(Bateman1 and Bateman2). It is currently believed that
AMP regulates the activity of AMPK by binding to the g
subunit. AMP binding also promotes the phosphorylation
of Thr172 in the activation loop of the kinase domain of
the a subunit, and inhibits the dephosphorylation of this
residue by phosphatases. Binding assays suggest that
each Bateman domain can bind one AMP or ATP mole-
cule, and the full-length g subunit can bind two AMP
molecules (Hardie and Sakamoto, 2006; Scott et al., 2004).
The functional importance of the CBS motifs is under-
scored by the observation that mutations in them have
been linked to many human diseases (Hardie and Saka-
moto, 2006; Kahn et al., 2005; Scott et al., 2004). For
AMPK, mutations in the g2 subunit (R302Q, H383R,
T400N, N488I, R531G, R531Q, and the insertion of a Leu
after residue 350; Figure 1) are the cause of the Wolff-
Parkinson-White (WPW) syndrome, which is characterized
by arrhythmia, hypertrophy, and a glycogen storage dis-
order in the heart. In Hampshire pigs, an R200Q mutation
in the g3 subunit, equivalent to the R302Q mutation in the
g2 subunit (Figure 1), causes a glycogen storage disease
in skeletal muscle (Milan et al., 2000). In comparison, the
adjacent V199I polymorphism is associated with low65–74, January 2007 ª2007 Elsevier Ltd All rights reserved 65
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Crystal Structure of the Bateman2 Domain of Snf4Figure 1. Sequence Alignment of Yeast Snf4 and Human AMPK g1, g2, and g3 Subunits
The secondary structure elements are labeled. Residues shown in green are in the hydrophobic core of the monomer, whereas those in magenta are
in the dimer interface of the Bateman2 domain of Snf4. Residues shown in red are sites of disease-causing mutations, and the red arrowhead indi-
cates the position of an insertion mutation. Equivalent residues in the four CBS motifs are aligned vertically.glycogen level in skeletal muscle (Ciobanu et al., 2001).
Mutations of CBS motifs in other proteins are linked to
homocystinuria, retinitis pigmentosa, Bartter syndrome,
and other diseases.
These mutations in the g subunit may disrupt the activa-
tion of the kinase by AMP. Binding studies show that the
mutations generally decrease the affinity between the g
subunit and AMP (Scott et al., 2004). Some of the muta-
tions may also increase the basal activity of the kinase,
which may explain the dominant, gain-of-function behav-
ior of these mutations (Hamilton et al., 2001; Kahn et al.,
2005).
In yeast, the ortholog of AMP-activated protein kinase,
known as SNF1 (Hardie et al., 1998), has important roles
in the transcription of genes repressed by glucose as
well as in other biological processes. SNF1 also contains
three subunits—the catalytic a subunit (Snf1) and the reg-
ulatory b (Sip1, Sip2, Gal83) and g (Snf4) subunits. In con-
trast to mammalian AMPK, however, Snf4 does not appear
to bind AMP (Hardie et al., 1998; Kahn et al., 2005), and
how the SNF1 heterotrimer is activated remains unclear.
Crystal structures of several CBS motifs have been
determined (Meyer and Dutzler, 2006; Miller et al., 2004;
Zhang et al., 1999), but so far no structural information is
available for the CBS motifs (Bateman domains) of
AMPK. To provide a molecular basis for understanding
the biochemical functions of the g subunit, we have deter-
mined the crystal structure of the Bateman2 domain of
Snf4 at 1.9 A˚ resolution. The structure revealed a dimeric
association of the Bateman2 domain, and sequence anal-
ysis suggests that residues at the dimer interface are
also conserved in the Bateman1 domain. The Bateman2
domain of yeast Snf4 shares 36% sequence identity with
that of the mammalian g2 subunit, and our structure is
therefore an excellent model for the mammalian Bateman
domains. The structural information has implications for
AMP binding by these domains.66 Structure 15, 65–74, January 2007 ª2007 Elsevier Ltd All rigRESULTS AND DISCUSSION
Overall Structure of the Bateman2 Domain of Snf4
The crystal structure of the Bateman2 domain (corre-
sponding to the third and fourth CBS motifs) of yeast
Snf4 has been determined at 1.9 A˚ resolution, based on
a bacterial expression construct that contains residues
179–322 of the protein, Snf4(179–322). The refined struc-
tures have excellent agreement with the crystallographic
data and the expected bond lengths, bond angles, and
other geometric parameters (Table 1). The majority of
the residues (92%) are in the most favored region of the
Ramachandran plot, and none of the residues are in the
disallowed region.
The current refined model in the native crystal contains
residues 181–248, 253–265, and 272–320 of Snf4
(Figure 2A; see Figure S1 in the Supplemental Data avail-
able with this article online), while no electron density
was observed for residues 249–252, 266–271, and those
at the N and C termini of the recombinant protein (including
the hexa-histidine tag at the C terminus). These residues
are probably disordered in these crystals. The same seg-
ments of the protein are missing in the structure of the
selenomethionyl protein. The monomers in these crystals
have roughly the same conformation, with an rms distance
of 0.5 A˚ for their equivalent Ca atoms.
The structure shows that the CBS3 motif contains resi-
dues 198–269, while CBS4 contains 270–322 (Figure S1).
Each motif contains a three-stranded antiparallel b sheet
with helices on one side. The two CBS motifs have the
same fold, with an rms distance of 0.7 A˚ for 47 pairs of
Ca atoms between them (Figure S1). They are related by
a pseudo 2-fold axis (Figure S1), but the sequence identity
among their structurally equivalent residues is 21%. The
two motifs have strong interactions with each other,
predominantly through the open face of their b sheets (Fig-
ure S1), as was observed originally in the structure of thehts reserved
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Crystal Structure of the Bateman2 Domain of Snf4CBS motifs of inosine 50-monophosphate dehydrogenase
(IMPDH) (Zhang et al., 1999).
The structural similarity between CBS3 and CBS4 al-
lowed us to produce an overall alignment of the four CBS
motifs in the g subunits of AMPK (Figure 1). We propose
a systematic nomenclature for the secondary structure
elements in these motifs, where for example the three
b strands in CBS3 are named b3A, b3B, and b3C and the
three helices a3A, a3B, and a3C (Figure 1).
Remarkably, residues 181–197, prior to CBS3 in the pri-
mary sequence, form a short helix (a3) and a short b strand
(b3) in the structure and interact with residues in CBS4
(Figure 2A; Figure S1). The strand is hydrogen-bonded
to b4C in CBS4, extending that b sheet to four strands. It
is likely that the conformations of these residues are main-
tained in the full-length Snf4 protein, as the Phe-Leu motif
at the beginning of a3 helps bury the hydrophobic core
of CBS4 (Figure S1). Residues preceding CBS1 could
also form a similar structure for the Bateman1 domain,
as the Phe-Leu motif in the a3 helix is also present in the
segment preceding CBS1 (Figure 1). Therefore, the Bate-
man2 domain of Snf4 appears to cover residues 181–322,
whereas the Bateman1 domain may contain residues
23–180 (Figure 1).
A Dimer of the Bateman2 Domain of Snf4
Our crystallographic analyses reveal a dimer of the Bate-
man2 domain of Snf4 (Figure 2A), and the same dimer is
observed in both crystal forms of this protein. A total of
1400 A˚2 of the surface area of each monomer is buried at
Table 1. Summary of Crystallographic Information
Protein Native Selenomethionyl
Space Group P3221 F432
Maximum resolution (A˚) 1.9 2.5
Number of observations 44,397 251,516
Rmerge (%)
a 6.1 (40.0) 9.8 (62.0)
I/sI 27.4 (3.5) 28.0 (5.9)
Resolution range used
for refinement
55–1.9 50–2.5
Number of reflectionsb 11,241 19,087
Completeness (%) 100 (99) 99 (99)
R factor (%)c 20.4 (21.5) 23.9 (28.3)
Free R factor (%) 23.8 (27.7) 26.7 (33.6)
Rms deviation in
bond lengths (A˚)
0.015 0.010
Rms deviation in
bond angles ()
1.5 1.2
PDB accession code 2NYC 2NYE
a Rmerge =
P
h
P
ijIhi  hIhij=
P
h
P
i Ihi: The numbers in paren-
theses are for the highest resolution shell.
b The number for the selenomethionyl protein includes both
Friedel pairs.
c R=
P
hjFoh  Fch j=
P
hF
o
h :Structure 1the dimer interface, suggesting that the dimer should be
stable. Light-scattering studies confirmed that the Bate-
man2 domain of Snf4 is dimeric in solution (Figure S2).
The dimer is formed by the head-to-tail arrangement of
the two monomers, such that the CBS3 motif of one mono-
mer is in contact with the CBS4 motif of the other monomer
(Figure 2A). The overall shape of the dimer is similar to
a disk, with a diameter of about 45 A˚ and a thickness of
25 A˚ (Figure 2B).
Most of the interactions at the dimer interface are medi-
ated by the aA and aB helices in each CBS motif, and they
form a four-helical bundle in the interface (Figure 2A). Each
of these helices contains several exposed hydrophobic
residues (Ile212 and Thr216 in a3A; Tyr239, Leu242, and
Ile245 in a3B; Met284 in a4A; and Leu310, Leu314,
Ile317, and Leu318 ina4B) (Figure 1), which become buried
upon dimer formation (Figure 2C). In addition, the aA-bB
loop in each CBS motif is positioned adjacent to the
2-fold axis of the dimer, and several functionally important
residues (Ser221, His293, Arg294, and Thr309) are located
in this region (Figure 2C, and see below). Residues in the
dimer interface of the Bateman2 domain are also con-
served in the Bateman1 domain (Figure 1).
Both head-to-head and head-to-tail dimeric asso-
ciations of CBS tandem pairs have been observed for
proteins from prokaryotic organisms, with unknown func-
tions (Miller et al., 2004). These structures are exemplified
by the Protein Data Bank entries 1PBJ and 1O50 (head-
to-tail dimers; Figure 3A) and 1PVM and 1YAV (head-to-
head dimers; Figure 3B). The structures of the head-to-
tail dimers are remarkably similar to that of the Bateman2
domain of Snf4 (Figure S3). Moreover, all of these CBS tan-
dem pairs contain an N-terminal extension, having a struc-
ture that is similar to that for residues 181–197 of Snf4
(Figure 2A; Figure S3).
A common feature of these dimeric CBS tandem pairs is
the hydrophobic surface of the aA and aB helices, which
mediates the self-association. In contrast, those CBS
motifs that have a hydrophilic surface for these two helices,
for example the CBS motifs of IMPDH (Zhang et al., 1999),
are monomeric. An interesting example is observed in
the structure of TM0892 from Thermotoga maritima (PDB
entry 1VR9). The aA and aB helices in the second CBS
motif have a hydrophobic surface and mediate its self-
association in a tail-to-tail manner (Figure 3C). In contrast,
the aA and aB helices in the first CBS motif have a hydro-
philic surface, and they are splayed away from each other
in the dimer (Figure 3C).
The CBS motifs of the ClC channel are also dimeric in
solution (Meyer and Dutzler, 2006). A head-to-tail dimer
similar to that observed for Snf4 here is proposed, although
that CBS motif is monomeric in the crystal.
The Bateman Domains May Function as Dimers
To assess the stability of the observed dimer of the Snf4
Bateman2 domain, we mutated several residues in the
dimer interface and expressed the L242E, R291A, H293E,
R294Q, L314E single mutant proteins and the L242E/
H293E, R291A/H293E, L242E/H293E/R291A double and5, 65–74, January 2007 ª2007 Elsevier Ltd All rights reserved 67
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Crystal Structure of the Bateman2 Domain of Snf4Figure 2. Structure of the Bateman2 Domain Dimer of Snf4
(A) Schematic representation of the Bateman2 domain dimer. One monomer is shown in yellow and the other in cyan. The red oval indicates the 2-fold
axis of symmetry of the dimer.
(B) The dimer after 90 rotation around the vertical axis, showing the disk shape of the structure.
(C) Stereo drawing showing detailed interactions at the dimer interface of the Bateman2 domain. Residues equivalent to sites of disease-causing
mutations in mammalian g subunits are labeled in red. Only half of the dimer interface is shown. Produced with Ribbons (Carson, 1987).triple mutant proteins. Light-scattering studies showed
that all these mutant proteins are still dimeric in solution
at high concentrations (Figure S2), suggesting that the
dimer may be rather stable, consistent with the large sur-
face area burial (1400 A˚2) in the interface.
We next examined the effects of these mutations in yeast
cells. It seemed possible that any effects on dimerization
would be more pronounced when the mutant protein was
present at its native levels and that these mutations could
affect the function of Snf4 in the context of the SNF1 holo-
enzyme. We created these mutations in a centromeric
plasmid expressing full-length Snf4 under the control of68 Structure 15, 65–74, January 2007 ª2007 Elsevier Ltd All rigthe native promoter, and the mutant plasmids were used
to transform yeast cells lacking wild-type Snf4. The single
and double mutations had modest effects on SNF1 activity
(less than 2-fold reduction), and the L242E/H293E/R291A
triple mutation caused a 5-fold decrease in activity (Figures
4A and 4B). The expression level of the triple mutant protein
was about 2-fold lower than that of the wild-type protein
(Figure 4D). The L314E mutant protein was also tested,
but expression levels were very low (data not shown).
These findings suggest that multiple mutations in the
Snf4 dimer interface are needed to affect SNF1 activity,
possibly by disrupting the dimerization of Snf4, consistenthts reserved
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Crystal Structure of the Bateman2 Domain of Snf4Figure 3. Structures of Representative
Bateman Domain Dimers
(A) Structure of the head-to-tail dimer of
TM0935 from Thermotoga maritima (PDB entry
1O50) (Miller et al., 2004).
(B) Structure of the head-to-head dimer of Ykul
from Bacillus subtilis (PDB entry 1YAV).
(C) Structure of the tail-to-tail dimer of TM0892
from Thermotoga maritima (PDB entry 1VR9).
There are no interactions at the other half
of the interface, as it is hydrophilic in nature.
Produced with Ribbons (Carson, 1987).with the stability of the dimer. Larger effects on the activity
of SNF1 could be expected if the Bateman1 domain were
mutated at the same time.Structure 15,We also obtained experimental evidence for the self-
association of full-length Snf4. HA- and LexA87-tagged
Snf4 were overexpressed from plasmids in snf4D mutantFigure 4. SNF1 Catalytic Activity Assay
(A) Wild-type and mutant Snf4 proteins, or no
protein (vector pRS313), were expressed at
native levels from plasmids in snf4D mutant
yeast cells. Cells were grown in high glucose
and collected by centrifugation, which acti-
vates SNF1 protein kinase. Three indepen-
dent extracts were prepared, and SNF1 was
assayed for phosphorylation of the SAMS
peptide substrate.
(B) SNF1 activity assay, where the cells were
collected by filtration, and resuspended in
0.05% glucose for 5 min to activate Snf1.
Two independent extracts were assayed for
SNF1 activity. Error bars are standard devia-
tions for at least 6 assays.
(C) Fractions used in assays for (A) were ana-
lyzed by immunoblotting with anti-Snf1 and
anti-Snf4.
(D) Fractions used in assays for (B) were ana-
lyzed by immunoblotting with anti-Snf1 and
anti-Snf4. To compare levels of Snf1 protein
in the wild-type and triple mutant extracts,
2-fold and 4-fold dilutions of the wild-type
sample were loaded (right panel).65–74, January 2007 ª2007 Elsevier Ltd All rights reserved 69
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Crystal Structure of the Bateman2 Domain of Snf4yeast cells lacking the native protein. HA-Snf4 was
immunoprecipitated from cell lysates with anti-HA, and
immunoblot analysis detected coprecipitation of a fraction
of the LexA87-Snf4 (Figure 5). In control experiments, no
LexA87-Snf4 was recovered from extracts containing HA
alone. Similar results were obtained when cells were
grown in abundant glucose or were subjected to glucose
deprivation to activate SNF1 protein kinase. These find-
ings are compatible with the model that Snf4 dimerizes
in vivo. It remains possible that another protein (for exam-
ple, Snf1 and/or one of the b subunits) mediated the asso-
ciation of the differently tagged proteins; however, Snf4
was overexpressed, whereas other proteins were present
at endogenous levels. Overall, our structural and bio-
chemical studies suggest that Snf4 and its Bateman
domains may function as dimers.
A Model for the Bateman Domains of Mammalian
AMPK
The Bateman2 domain of yeast Snf4 shares 36% se-
quence identity (52% similarity) with that of the g2 subunit
of mammalian AMPK (Figure 1). Moreover, there are no
gaps in this sequence alignment. Therefore, our structure
of the Bateman2 domain of Snf4 is an excellent model for
the mammalian Bateman2 domains. There are only a few
noticeable differences between the mammalian and Snf4
Bateman2 domains in the dimer interface. For example,
the Ala238 residue of Snf4 is replaced by a Lys or Arg in the
mammalian g subunits (Figure 1), which introduces an
additional positive charge in this region (see below). These
substitutions are unlikely to disrupt the dimer association.
The sequence homology between the Bateman2 and
Bateman1 domains is much weaker (Figure 1), but they
are expected to share significant structural similarity.
Therefore, our structure of the Bateman2 domain of Snf4
should also be a good model for the Bateman1 domain
of mammalian AMPK.
Implications for AMP Binding by the Bateman
Domains
A model for the complex of AMP with the Bateman1 do-
main of the g1 subunit, based on the structure of IMPDH,
was proposed earlier where the Bateman domain func-
tions as a monomer (Adams et al., 2004). Our structural
and biochemical studies suggest however that the g
subunit may be a dimer, with two disks for the two head-
to-tail Bateman domain dimers, implying a (abg)2 stoichi-
ometry for AMPK. While the native AMPK complex is
believed to have the stoichiometry of abg, a highly asym-
metric shape was proposed to explain the observed MW
of 230 kDa for this complex (Davies et al., 1994; Neumann
et al., 2003), as the theoretical MW of this complex is only
130 kDa. It is possible that the observed MW actually
corresponds to a dimer, (abg)2. Moreover, it has been
suggested that the kinase domain of Snf1 also dimerizes
(Nayak et al., 2006), although our data on this domain
suggest this self association has low affinity (Rudolph
et al., 2005).70 Structure 15, 65–74, January 2007 ª2007 Elsevier Ltd All rigThere is a prominent, electropositive pocket at the cen-
ter of one face of the Bateman2 dimer disk (Figure 6A),
while the other face is predominantly electronegative
(Figure S4). This pocket could be the binding site for
AMP or ATP (Figure 6B). This hypothesis is further sup-
ported by the fact that most of the disease-causing muta-
tions are located in this pocket (Figure 6C). Binding studies
show that these mutations generally reduce the affinity of
the g subunit for AMP (Scott et al., 2004). Therefore, this
model would provide a molecular basis for the disease-
causing effects of these mutations.
The possibility of a monomeric organization of the g
subunit, where the Bateman1 and Bateman2 domains
directly contact each other and mimic a Bateman domain
homodimer, cannot be excluded based on our data. The
two domains are likely to be arranged in a head-to-head
fashion in such a structure (Figure 6D), however, as the
linker between them is not long enough to allow a head-
to-tail dimer (Figure 6B). Such head-to-head dimers have
been observed for bacterial CBS tandem pairs (Figure 3B),
and can be formed by flipping one of the Bateman domains
around its pseudo 2-fold axis (Figure 6D). This will split
in half the pocket in the center of the head-to-tail dimer
(Figure 6A), and there would instead be two smaller
pockets, one on each face of the disk (Figure 6E).
Recent data suggest each g subunit can bind two AMP
or ATP molecules (Scott et al., 2004). The head-to-head
Figure 5. Coimmunoprecipitation Data Showing Self-Associ-
ation of Snf4
Yeast cells (snf4D) overexpressed LexA87-Snf4 and HA-Snf4 or HA
alone (vector). Cultures were grown in high glucose (+) or shifted for
5 min to glucose-limiting conditions (), which activate Snf1 protein
kinase. Cell lysates were prepared, and proteins were immunopre-
cipitated with anti-HA antibody. Immunoprecipitates (100 mg) and
input proteins (50 mg) were subjected to immunoblot analysis with
anti-HA and anti-LexA antibodies. The two upper panels are taken
from the same exposure of the blot.hts reserved
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Crystal Structure of the Bateman2 Domain of Snf4Figure 6. A Possible AMP Binding Pocket in the Center of the Bateman Domain Dimer
(A) Molecular surface of one face of the Bateman2 domain dimer of mammalian g2 subunit model.
(B) A cartoon of the head-to-tail Bateman domain dimer, and the proposed AMP-binding site in the center.
(C) Schematic drawing of the pocket in the center of the Bateman2 domain dimer of the g2 subunit. Residue numbers are for the Bateman2 domain,
and those in parentheses are their equivalents in the Bateman1 domain. Residues that are sites of disease-causing mutations are labeled in red.
(D) A cartoon of the g subunit monomer, with the two Bateman domains arranged in a head-to-head fashion. There is another binding site on the other
face of the disk.
(E) Molecular surface of one face of the head-to-head dimer of the Bateman2 domain, representing the head-to-head organization of the g subunit
monomer. The star indicates the half pocket that is shared with that in the head-to-tail dimer. (A) and (E) were produced with Grasp (Nicholls et al.,
1991), and (C) was produced with Ribbons (Carson, 1987).monomeric organization of the g subunit (Figure 6D) would
be consistent with this stoichiometry, while the head-to-tail
dimeric organization (Figure 6B) would not. Both models,
however, suggest that the Bateman domains alone are
dimeric, while a monomeric form of the domain was as-
sumed in analyzing the binding data (Scott et al., 2004).
Moreover, the Bateman domains were expressed as GST
fusion proteins for the binding assays (Scott et al., 2004),Structure 15,which is expected to enhance their dimerization. Further
experiments are needed to reconcile this difference in
stoichiometry between our model and the binding data.
Our model also provides an explanation why yeast Snf4
does not bind AMP. Sequence comparisons show that
a His residue at the beginning of b2B in mammalian Bate-
man1 domain is replaced by a Gly residue in Snf4 (Figure 1).
Mutation of this His residue in theg1 subunit to Gly (H151G,65–74, January 2007 ª2007 Elsevier Ltd All rights reserved 71
Structure
Crystal Structure of the Bateman2 Domain of Snf4equivalent to His530 in Figure 6C) is sufficient to render the
mammalian AMPK complex insensitive to AMP (Adams
et al., 2004). Moreover, a mutation at the equivalent posi-
tion in theg2 subunit, H383R, is linked to the WPW disease.
These observations may explain why the Bateman1 do-
main of Snf4 cannot bind AMP. In the Bateman2 domain,
the largest difference between Snf4 and the mammalian
g subunits in this pocket is possibly the substitution of
a Lys/Arg residue in the g subunits (Lys475 in g2) by
Ala238 in Snf4 (Figure 1). This additional positive charge
may be a determining factor in AMP binding by the mam-
malian proteins. The natural ligand that activates the
SNF1 complex in yeast remains to be identified.
In summary, we have determined the high-resolution
structure of the Bateman2 domain of yeast Snf4. A dimeric
association of this domain was revealed by the structure,
which we have confirmed by solution light-scattering and
mutagenesis studies. The Bateman domains therefore
appear to function as dimers. We have identified a promi-
nent pocket in the center of the dimer, which may be the
binding site for AMP or ATP. This hypothesis is supported
by the fact that most of the disease-causing mutations,
which are known to reduce the affinity of the Bateman
domain for the nucleotide, are located in this pocket. Our
structural and functional studies provide molecular
insights into the regulation of AMPK by the adenine
nucleotides.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Residues 179–322 of yeast Snf4, Snf4(179–322), containing CBS3 and
CBS4 motifs, were subcloned into the pET26b vector and overex-
pressed in E. coli at 20C. The soluble protein was purified by nickel
affinity and gel filtration chromatography. The protein was concen-
trated to 10 mg/ml in a solution containing 50 mM Tris (pH 8.5), 100
mM NaCl, 5 mM DTT, and stored at 80C. The recombinant protein
contains a C-terminal hexa-histidine tag, which was not removed for
crystallization.
The selenomethionyl protein was produced in B834(DE3) cells
(Novagen), grown in defined LeMaster media supplemented with sele-
nomethionine (Hendrickson et al., 1990), and purified following the
same protocol as that for the native protein.
Protein Crystallization
Trigonal and cubic crystal forms of Snf4(179–322) were obtained.
The trigonal crystal form was obtained with the native protein at
21C by the sitting-drop vapor diffusion method. The protein was at
10 mg/ml concentration. The reservoir solution contained 100 mM
NaAcetate (pH 4.5), 30% (w/v) PEG4000 and 200 mM (NH4)Acetate.
The crystal belongs to space group P3221, with cell parameters of
a = b = 64.2 A˚ and c = 61.1 A˚. There is one Snf4(179–322) molecule in
the asymmetric unit.
The cubic crystal form was obtained with the selenomethionyl
protein at 21C by the sitting-drop vapor diffusion method. The protein
was at 10 mg/ml concentration. The reservoir solution contained
100 mM NaAcetate (pH 4.5), 30% (w/v) PEG4000, 200 mM (NH4)For-
mate, and 3% Benzamidine. The crystal belongs to space group
F432, with cell parameters of a = b = c = 235.6 A˚. There are two
Snf4(179–322) molecules in the asymmetric unit.
The crystals were cryo-protected by the introduction of 20% (v/v)
glycerol and flash-frozen in liquid nitrogen for data collection at 100K.72 Structure 15, 65–74, January 2007 ª2007 Elsevier Ltd All riData Collection and Processing
X-ray diffraction data were collected at the X4A and X4C beamlines of
the National Synchrotron Light Source (NSLS). The diffraction images
were processed with the HKL package (Otwinowski and Minor,
1997). A selenomethionyl single-wavelength anomalous diffraction
(SAD) data set to 2.5 A˚ resolution was collected for the cubic form at
the X4C beamline (Hendrickson, 1991). For structure refinement, a
diffraction data set to 1.9 A˚ resolution was collected for the trigonal
crystal at the X4A beamline. The data processing statistics are summa-
rized in Table 1.
Structure Determination and Refinement
The Se sites were located using the SAD data with the program SnB
(Weeks and Miller, 1999). The reflection phases were determined with
the program Solve/Resolve (Terwilliger, 2003), which also automati-
cally located about 80% of the residues. The atomic model was built
with the program O (Jones et al., 1991). The trigonal crystal form was
solved by the molecular replacement method using a monomer in the
cubic form as the search model, with the program Molrep (Vagin and
Teplyakov, 2000). The structure refinement was carried out with the
programs CNS (Brunger et al., 1998) and Refmac5 (Murshudov et al.,
1997). The statistics on the structure refinement are summarized in
Table 1.
Mutagenesis
Mutants of Snf4 were created with the QuikChange kit (Stratagene) and
verified by sequencing. The mutant proteins were purified following the
same protocol as the wild-type enzyme.
SNF1 Assays
Centromeric plasmid pOV75 expresses Snf4 from the native promoter;
this plasmid contains a NotI site at the C terminus of the ORF and differs
from pOV76 (Vincent et al., 2001) in lacking GFP sequence. Wild-type
and mutant Snf4 proteins were expressed from pOV75 and its mutant
derivatives in Saccharomyces cerevisiae strain MCY2634 (snf4D2).
Cultures were grown to mid-log phase in selective synthetic complete
medium containing 2% glucose. Cells were collected by centrifugation,
which activates Snf1 protein kinase, or were collected by filtration,
shifted to 0.05% glucose for 5 min, and collected by filtration. Extracts
were prepared from at least two independent cultures, and Snf1 was
partially purified and assayed, at different protein concentrations,
for phosphorylation of the SAMS peptide (Davies et al., 1989), as
described (Hedbacker et al., 2004). Kinase activity is expressed as
nanomoles of phosphate incorporated into the peptide per minute
per milligram of protein. Assayed fractions were subjected to immuno-
blot analysis with anti-Snf1 (Celenza and Carlson, 1986) and anti-Snf4
(Estruch et al., 1992) antibodies.
Coimmunoprecipitation Studies
Proteins were expressed inSaccharomyces cerevisiae strain MCY5803
(snf4D::kanMX4). Snf4, tagged at the N terminus with a triple HA
epitope or the DNA binding domain of LexA (LexA87), was expressed
from the strong ADH1 promoter from plasmid pGP2 (derivative of vec-
tor pWS93) or pRJ58 (Jiang and Carlson, 1996), respectively. Cultures
were grown to mid-log phase in selective synthetic complete medium
containing 2% glucose. Cells were collected by filtration and frozen
at 80C or shifted to 0.05% glucose for 5 min, collected, and frozen.
Preparation of protein lysates and immunoprecipitation were as de-
scribed (Treitel et al., 1998). Protein (200 mg) was immunoprecipitated
with anti-HA (12CA5) and collected with rProtein A immobilized on
beads (RepliGen). Proteins were separated by electrophoresis in
12% SDS-polyacrylamide and subjected to immunoblot analysis with
anti-HA and anti-LexA (Invitrogen). Antibody was detected with ECL
Plus (Amersham).
Supplemental Data
Supplemental Data include four figures and are available at http://www.
structure.org/cgi/content/full/15/1/65/DC1/.ghts reserved
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